In previous studies, ACSL4 has been shown to be involved in a variety of diseases such as rectal cancer, bladder cancer, chronic obstructive pulmonary disease, acute kidney injury, and non-alcoholic steatohepatitis through the ferroptosis pathway [61, 101–104]. This evidence concerns the gene ACSL4 and metabolic dysfunction-associated steatohepatitis.